ConnSante BioTech & Innovation, INC.
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
ConnSante offers services such as the anti-cancer capability test, immune and tissue-repair system diagnostics, cancer prognosis and risk-assessment services, and tailored health-management and follow-up programs — particularly aimed at high-risk groups o
Founded Year
2025
Unified Business No.
60756906
Status
Active
Number of Employees
0
Total Paid-in
Capital
2,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
ConnSante Biotech is a molecular and cellular diagnostics company that, based on 25 years of research, developed a proprietary “anti-cancer capability test” designed to assess the health status of stem cells and immune cells — helping individuals evaluate cancer risk and manage long-term health.
